Digest Network How does it work
Network
/
Society
In
Not verified

Invivoscribe

What we write about

BiotechnologyHealthIndustriaOncologyPharmaceuticals

5 Press releases

View all press releases
05/02/2026
Industria
Oncology
Health
Tecnica
Software
Biotechnology
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
Source
Invivoscribe
Issuer
Business Wire
1.00
0
18/06/2025
Oncology
Health
Biotechnology
Sanità
Pharmaceuticals
Industria
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials
Source
Invivoscribe
Issuer
Business Wire
1.00
0
22/04/2025
Industria
Biotechnology
Health
Medical and health
Oncology
Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
Source
Invivoscribe
Issuer
Business Wire
1.00
0
27/03/2025
Industria
Biotechnology
Sanità
Health
Invivoscribe Announces Registration of the LeukoStrat® CDx FLT3 Mutation Assay in the United Kingdom and Switzerland
Source
Invivoscribe
Issuer
Business Wire
1.00
0
08/10/2024
Industria
Oncology
Medical and health
Health
Pharmaceuticals
Biotechnology
EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA
Source
Invivoscribe
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0